U.S. Markets close in 3 hrs 21 mins

Alnylam Pharmaceuticals, Inc. (ALNY)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
79.935+0.10 (+0.13%)
As of 12:39PM EDT. Market open.
People also watch
BMRNACORSGENACADALXN
Full screen
Previous Close79.830
Open80.500
Bid79.650 x 100
Ask79.880 x 100
Day's Range78.690 - 80.810
52 Week Range31.380 - 86.920
Volume538,626
Avg. Volume1,035,320
Market Cap7.31B
Beta3.47
PE Ratio (TTM)-16.55
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com6 hours ago

    [$$] Alnylam Selloff Looks Like an Overreaction

    Alnylam Pharmaceuticals (ALNY:Nasdaq) By Credit Suisse ($85.21, June 26, 2017) We are raising our target price on Alnylam Pharmaceuticals to $96 from $90 as we increased our probability of success from 40% to 60% in porphyria. At 100% success this adds $12 a share to our model (due to high operating leverage and modeling of fixed costs for the research platform). At 0% success to porphyria our discounted-cash-flow model is $18 a share lower at $78 a share.

  • 5 Best Biotech Stocks of 2017 So Far
    Motley Fool3 days ago

    5 Best Biotech Stocks of 2017 So Far

    How Alnylam, Puma, Immunogen, Sangamo, and Calithera beat all others to be the best biotech stocks of the year so far.

  • Why is Alnylam's (ALNY) Stock Close to 100% this Year?
    Zacks13 days ago

    Why is Alnylam's (ALNY) Stock Close to 100% this Year?

    Shares of Alnylam Pharmaceuticals, Inc. (ALNY) soared 93.3% this year so far massively outperforming the 2.6% increase registered by the Zacks classified Biomed/Genetics industry during this period.